Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric M Reiman

Showing results (271-280 of 434) with videos related to

Pageof 44
Sort By:
Alzheimer'S Research & Therapy|April 16, 2015
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's diseaseHaakon B Nygaard, Allison F Wagner, Garrett S Bowen, et al.
The New England Journal of Medicine|April 11, 2019
Tau Positron-Emission Tomography in Former National Football League PlayersRobert A Stern, Charles H Adler, Kewei Chen, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker StudyClara Vila-Castelar, Edmarie Guzmán-Vélez, Enmanuelle Pardilla-Delgado, et al.
Neurobiology of Aging|October 26, 2005
Gene expression correlates of neurofibrillary tangles in Alzheimer's diseaseTravis Dunckley, Thomas G Beach, Keri E Ramsey, et al.
Neuroimage|March 6, 2010
Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging InitiativeKewei Chen, Jessica B S Langbaum, Adam S Fleisher, et al.
Journal of Neuroscience Methods|August 4, 2010
Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairmentXia Wu, Kewei Chen, Li Yao, et al.
JAMA Neurology|July 10, 2013
Genetic susceptibility for Alzheimer disease neuritic plaque pathologyJoshua M Shulman, Kewei Chen, Brendan T Keenan, et al.
Neurology|July 13, 2012
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter studyP Murali Doraiswamy, Reisa A Sperling, R Edward Coleman, et al.
Neuroimage|October 5, 2010
Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriersWinnie S Liang, Kewei Chen, Wendy Lee, et al.
Neurobiology of Aging|August 11, 2012
Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individualsReisa A Sperling, Keith A Johnson, P Murali Doraiswamy, et al.
Pageof 44

Showing results (271-280 of 434) with videos related to

Sort By:
Pageof 44
Alzheimer'S Research & Therapy|April 16, 2015
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer's diseaseHaakon B Nygaard, Allison F Wagner, Garrett S Bowen, et al.
The New England Journal of Medicine|April 11, 2019
Tau Positron-Emission Tomography in Former National Football League PlayersRobert A Stern, Charles H Adler, Kewei Chen, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker StudyClara Vila-Castelar, Edmarie Guzmán-Vélez, Enmanuelle Pardilla-Delgado, et al.
Neurobiology of Aging|October 26, 2005
Gene expression correlates of neurofibrillary tangles in Alzheimer's diseaseTravis Dunckley, Thomas G Beach, Keri E Ramsey, et al.
Neuroimage|March 6, 2010
Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging InitiativeKewei Chen, Jessica B S Langbaum, Adam S Fleisher, et al.
Journal of Neuroscience Methods|August 4, 2010
Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairmentXia Wu, Kewei Chen, Li Yao, et al.
JAMA Neurology|July 10, 2013
Genetic susceptibility for Alzheimer disease neuritic plaque pathologyJoshua M Shulman, Kewei Chen, Brendan T Keenan, et al.
Neurology|July 13, 2012
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter studyP Murali Doraiswamy, Reisa A Sperling, R Edward Coleman, et al.
Neuroimage|October 5, 2010
Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal APOEε4 carriersWinnie S Liang, Kewei Chen, Wendy Lee, et al.
Neurobiology of Aging|August 11, 2012
Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individualsReisa A Sperling, Keith A Johnson, P Murali Doraiswamy, et al.
Pageof 44